Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oklo Inc (OKLO) vs Smith & Nephew plc (SNN) Price & Performance

Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Oklo Inc vs Smith & Nephew plc — how do they compare? Oklo Inc trades at $44.41 (market cap $7.68B), while Smith & Nephew plc trades at $29.95 (market cap $12.71B). The key difference: Smith & Nephew plc is the larger of the two by market cap, and Smith & Nephew plc pays a 2.59% dividend while Oklo Inc pays none. Which is the better fit depends on your goals.

OKLOSNN
Market Cap
$7.68B$12.71B
Sector
TechnologyHealth
52-Week High
$174.14$38.70
52-Week Low
$41.11$28.73
Enterprise Value
$5.47B$15.48B
Dividend Yield
2.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oklo Inc

OKLO trades at $41.51, up 0.97% today but remains in a significant downtrend with a 42% decline year-to-date. The stock shows bearish technical signals with negative profitability metrics including -8.87% ROE and consistent quarterly losses. Recent news highlights participation in a government nuclear power program for AI data centers, providing potential catalysts amid ongoing regulatory challenges and execution risks.

Despite analyst optimism with a $90.88 consensus target representing 119% upside, OKLO faces substantial execution and regulatory hurdles. The company burns significant cash with -$138.77M EBITDA while relying on financing activities. Long-term potential exists in nuclear energy demand, but near-term volatility and losses require careful risk assessment for investors.

Smith & Nephew plc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Oklo Inc

Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.

Read more on OKLO

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN